AGORA Cancer Research Center
AGORA was inspired by the vision that the integration of progress in cancer research into clinical practice can be accelerated by bringing together interdisciplinary research teams of clinicians, cancer biologists, immunologists, bio-informaticians and bio-engineers. Initiated by the ISREC Foundation in 2013, the AGORA building was opened in 2018. The functioning of this translational cancer research center reflects a partnership between the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL), the Swiss Federal Institute of Technology of Lausanne (EPFL), the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE).
Latest news
Events
AGORA Single-cell omics meetings | February 4th
Events
AGORA PRS Seminar | February 10th
Events
AGORA PRS Seminar | February 3rd
Events
PhD Thesis Defense | January 22nd
Latest publications
Tumor-derived aminopeptidase N promotes early stages of brain metastatic colonization.
Bejarano L, Hernández-Barranco A, Roh V, (…), Hegi ME, Fournier N, Joyce JA
Cell Reports – 2026 Feb 24
Hallmarks of cancer—Then and now, and beyond
Hanahan D
Cell – 2026 Jan 29
Kinetic Profiling in One-Step Digital Immunoassays Enables Multiplex Quantification across an Ultrabroad Dynamic Range.
Saateh A, Allamehnejad R, Yang W, (…), Liu YC, Tolstonog GV, Altug H
Journal of the American Chemical Society – 2026 Jan 27
Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumors.
Melero I, Steeghs N, Lassen U, (…), Dejardin D, Teichgräber V, Charo J
Journal for immunotherapy of cancer – 2026 Jan 16
The ubiquitin ligase KLHL6 drives resistance to CD8(+) T cell dysfunction.
Cheng H, Su Y, Pan X, (…), Gottardo R, Greenberg PD, Li G
Nature – 2026 Jan 14